Syncronis HPLC columns deliver greater consistency

Published: 15-Sep-2010
Manufacturing

Every column is individually tested, says Thermo Fisher

Thermo Fisher Scientific’s new Syncronis HPLC columns deliver consistent, predictable separations, from run to run and column to column.

The company says the range delivers exceptional reproducibility by providing highly pure, high surface-area silica, dense bonding and double end-capping.

Enhanced, automated column packing methods used within the Syncronis range assist in delivering greater consistency, and every column is individually tested to ensure that it meets the required specifications, the firm says.

Syncronis columns are available with 5µm particle size for conventional HPLC applications and with 1.7µm particle size for high-speed, high-efficiency UHPLC separations.

  • Companies:
  • Thermo Fisher Scientific
See more

You may also like

Manufacturing

Thermo Fisher Scientific opens manufacturing centre of excellence site in North Carolina

Read more
New manufacturing facility in Mebane (NC, US) site to significantly increase laboratory pipette production in the US

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Thermo Fisher Scientific opens manufacturing centre of excellence site in North Carolina

New manufacturing facility in Mebane (NC, US) site to significantly increase laboratory pipette production in the US
Manufacturing

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases
Manufacturing

Thermo Fisher's Accelerator CDMO and CRO solutions can slash drug development times by 3 years, study finds

The centralised solution can streamline the drug development process, facilitating the rapid commercialisation of new therapeutics
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating therapeutic manufacturing with smart and sustainable technologies

In this article, John Puglia, Senior Director of Research and Development, Single-Use Technologies, at Thermo Fisher Scientific, explores how innovative technologies are revolutionising biomanufacturing for a smarter, more sustainable future
Manufacturing

Ethris and Thermo Fisher Scientific to provide mRNA technology to biopharma market

Ethris will combine its mRNA technology platforms with Thermo Fisher's GMP manufacturing capacity to serve the biopharmaceutical market
Manufacturing

Thermo Fisher Scientific to invest $2bn into US manufacturing capabilities

The life science service provider will put 75% of the $2bn into its US pharmaceutical manufacturing capacities, helping to produce key medicines for the market
Manufacturing

Thermo Fisher Scientific introduces the 5L DynaDrive Single-Use Bioreactor

First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact; to simplify and accelerate process development and help bring therapies to market faster
Subscribe now